Efficacy of low-dose amiodarone in the prevention of paroxysmal atrial fibrillation resistant to type IA antiarrhythmic drugs

American Journal of Therapeutics

Volumn 7, Issue 4, 2000, Pages 245-250

  Kerin, Nicholas Z ^a,c   Faitel, Kathy ^a   Kerin, Iris A ^a   Quinones, Luchi ^b   Stomel, Robert J ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Michigan Institute for Heart Failure   (United States)

^c SINAI GRACE HOSPITAL   (United States)

Author keywords

Amiodarone; Amiodarone side effects; Atrial fibrillation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

AGED; ARTICLE; CLINICAL TRIAL; DRUG RESISTANCE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MALE; MIDDLE AGED;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 0034252749     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200007040-00004     Document Type: Article

References (23)

1. Kerin NZ, Frumin H, Cohen IS, et al: Atrial fibrillation. In: Difficult Medical Management. (Ed. Taylor RB). W. B. Saunders, Philadelphia, 1991, pp 100-106.
2. Radford MD, Evans DW: Long-term results of DC reversion of atrial fibrillation. Br Heart J 1968;30:91-96.
3. Sodermark T, Jonsson B, Olsson A, et al: Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter: A multicenter study from Stockholm. Br Heart J 1975;37:486-492.
4. Lloyd EA, Gersh BJ, Forenau R: The efficacy of quinidine and disopyramide in the maintenance of sinus rhythm after electroconversion from atrial fibrillation. S Afr Med J 1984;65:367-369.
5. Anderson JL: Multifocal atrial tachycardia, atrial flutter and atrial fibrillation. In: Cardiac Arrhythmias: Current Diagnosis and Practical Management. (Ed. Winkle RW). Addison-Wesley, Menlo Park, 1983, pp 206-260.
6. Zipes DP: Specific arrhythmias: Diagnosis and treatment. In: Heart Disease: A Textbook of Cardiovascular Medicine. (Ed. Braunwald E). W. B. Saunders, Philadelphia, 1988, pp 658-682.
7. Wheeler PJ, Puritz R, Ingram DV, et al: Amiodarone in the treatment of refractory supra-ventricular and ventricular arrhythmias. Postgrad Med J 1979;55:1-9.
8. Ward DE, Camm AJ, Spurrell RAJ: Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal atrial fibrillation. Br Heart J 1980;44:91-95.
9. Graboys TB, Podrid PJ, Lown B: Efficacy of amiodarone for refractory supraventricular tachyarrhythmias. Am Heart J 1983;106:870-876.
10. Horowitz LN, Spielman SR, Greenspan AM, et al: Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy. J Am Coll Cardiol 1985;6:1402-1407.
11. Blevins RD, Kerin NZ, Benederet D, et al: Amiodarone in the management of refractory atrial fibrillation. Arch Intern Med 1987;147:1401-1404.
12. Tuzcu ME, Gilbo J, Masterson M, et al: The usefulness of amiodarone in management of refractory supraventricular tachyarrhythmias. Cleve Clin J Med 1989;56:238-242.
13. Kerin NZ, Blevins, Faitel K, et al: Intravenous and oral loading versus oral loading alone with amiodarone for chronic refractory ventricular arrhythmias. Am J Cardiol 1985;55:89-91.
14. Ingram DV: Ocular effects of long-term amiodarone therapy. Am Heart J 1983;106:902-905.
15. Morganroth J, Horowitz LN: Flecainide: Its proarrhythmic effect and expected changes on the surface electrocardiogram. Am J Cardiol 1984;53:89B-94B.
16. Storey GC, Holt DW, Holt P, et al: High performance liquid chromatographic measurement of amiodarone and its desethyl metabolite: Methodology and preliminary observations. Ther Drug Monit 1982;4:385-388.
17. Podrid PJ, Lown B: Amiodarone therapy in symptomatic sustained atrial and ventricular tachyarrhythmias. Am Heart J 1981;101:374-379.
18. Rosenbaum MB, Chaile PA, Halpern MS, et al: Clinical efficacy of amiodarone as an antharrhythmic agent. Am J Cardiol 1976;38:934-944.
19. Vitolo E, Tronci M, Larovere MT, et al: Amiodarone versus quinidine in the prophylaxis of atrial fibrillation. Acta Cardiol 1981;36:431-444.
20. Kerin NZ, Rubenfire M, Blevins RD, et al: Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone. Clin Cardiol 1988;II:31-40.
21. Kerin NZ, Aragon E, Faitel K, et al: Long-term efficacy and toxicity of high and low-dose amiodarone regimens. J Clin Pharmacol 1989;29:418-23
22. Nitsch J, Manz M, Steinbeck G, et al: Relation of amiodarone drug level to efficacy and toxicity. Clin Prog Electrophys Pacing 1986;5:402-408.
23. Kerin NZ, Blevins RD, Frumin H, et al: Intravenous and oral loading versus oral loading alone with amiodarone for chronic refractory ventricular arrhythmias. Am J Cardiol 1985;55:89-91.